Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 31, 2026
Reporting period
Not applicable
Filed with the SEC
Apr 2, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000064803-26-000042
Filed / recorded
Apr 2, 2026, 8:57 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
CVS HEALTH Corp
Issuer CIK
64803
Ticker
CVS
Reporting person
Brian Newman
Relationship
Officer
Officer title
EVP, Chief Financial Officer
Security
Common Stock (RSUs)
Table
Non-derivative (Table I)
Transaction date
Mar 31, 2026
Transaction code
A
Shares / units
19,493
Price per share
$71.82
Acquired / disposed
Acquired (A)
Shares owned after
41,354
Ownership form
Direct
Amendment
No
Footnotes from the filing
Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.